Articles related to Dermatology

In this Cleveland Clinic article, an internal medicine specialist discusses the different levels of COVID-19 infection risk in delivery, patio dining, and delivery for those that want food from a restaurant. The basics are covered, including wearing a mask to protect your server, but the article also discusses the attention that should be paid to restaurant air quality.

In this article from the Patient Pages of JAMA, it’s said that the risk of contracting coronavirus disease 2019 (COVID-19) during air travel is lower than from an office building, classroom, supermarket, or commuter train. Read on to educate your patients on the precautions they can take – and why – to ensure their flying experience is a safe one.

If your medical tools resemble those found in the doctor’s bag of yore, consider elevating your treatment style–and your own quality of life–and look to these gadgets for a new level of precision and care. Reliable devices still exist and should be used – but have you upgraded your arsenal recently? Discover the essential technology that’s pushing medicine to new heights.

In this commentary from The Lancet, the author suggests that COVID-19 is not a pandemic, but a syndemic, which is defined as a set of linked health problems involving two or more afflictions, interacting synergistically, and contributing to excess burden of disease in a population. The syndemic approach reveals biological and social interactions that are important for prognosis, treatment, and health policy.

In this feature from the British Medical Journal (BMJ), associate editor Peter Doshi explores the emerging research on immunological responses to COVID-19. Is it true that the human population had no pre-existing immunity to SARS-CoV-2? The article attempts to answer this question with a deeper discussion around herd immunity, T cells, antibodies, and more.

In Study CK-301-101, the primary efficacy endpoint was objective response rate (complete + partial response, by independent central review), which was 47% (n = 15) in 32 metastatic cutaneous squamous cell carcinoma (mCSCC) patients evaluable for response, including three complete responses and 12 partial responses. The results from the study were presented at the ESMO Congress.